Partner With Us NRI

Company details

6M Return -23.72%
1Y Return -10.23%
Mkt Cap.(Cr) 4,597.02
Volume 983
Div Yield 0.10%
OI Chg %
Volume 983

Open Free Demat Account Online with ICICIDIRECT


  • swot

  • technicals

  • deals

  • shareholding


Delivery and volume

Our Research View

Trading recommendation

Tatva Chintan Pharma Chem Ltd

Call Date

15 Jul 2021

Entry Price


Target Price



Stop Loss



Investment recommendation

Data not found


  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio


Operating Profit(Cr.)

Profit after Tax(Cr.)


Reserves and Surplus



Operating Profit

Profit after tax





Equity Capital: 165.97 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 30,916.98 -44,588.21
LAST 3M 83,461.15 -41,404.02
LAST 6M 143,250.83 -190,265.70
LAST 12M 204,102.65 -163,801.53
  • Announcement
  • Corporate action
  • No Data Found

Date Action Type Ratio
No data found


  • About Company
  • Company Info
  • Listing Info
  • Tatva Chintan Pharma Chem Ltd was incorporated as `Tatva Chintan Pharma Chem Private Limited` pursuant to a certificate of incorporation dated June 12, 1996 issued by the Registrar of Companies, Gujarat and Dadra & Nagar Haveli at Ahmedabad ("RoC"). Thereafter, pursuant to the conversion of the Company to a public limited company, the name of our Company was changed to `Tatva Chintan Pharma Chem Limited`, and a fresh certificate of incorporation dated February 26, 2021 was issued to our Company by the RoC. The company is a specialty chemicals manufacturing company engaged in the manufacture of a diverse portfolio of structure directing agents ("SDAs"), phase transfer catalysts ("PTCs"), electrolyte salts for super capacitor batteries and pharmaceutical and agrochemical intermediates and other specialty chemicals ("PASC"). The company is the largest and only commercial manufacturer of SDAs for zeolites in India. It also enjoys the second largest position globally. In addition, the Company is one of the leading global producers of an entire range of PTCs in India and one of the key producers across the globe In 2004, the company received licence to manufacture for sale (or for distribution) of certain drugs from the Food and DrugsControl Administration, Gujarat at the Ankleshwar Manufacturing Facility In 2007, there was an expansion of manufacturing capacity at the companies Ankleshwar Manufacturing Facility In 2011, the company started commercial manufacturing of SDAs In 2015, 2017 and 2018, the company set up Warehousing facility in netherlands, set up Dahej manufacturing facility and set up R&D manufacturing facility in Vadodara respectively. In 2020, the company converted Ankleshwar Manufacturing Facility to a `zero liquid effluent discharge facility` and also during the year 2020 under review, there was a increase in manufacturing capacity at the companies Dahej Manufacturing Facility resulting in an increase in the aggregate manufacturing capacity of the Company from 160 KL and 10 Assembly Lines to 280 KL and 13 Assembly Lines.

Read More

No Data Found

AGM Date (Month) : Oct
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 543321
Book Closure Date (Month) :
BSE Group : B
ISIN : INE0GK401011

ICICIdirect Tatva Chintan Pharma Chem Ltd FAQ

You can buy Tatva Chintan Pharma Chem Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Tatva Chintan Pharma Chem Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 16, 2022 04:01 PM the closing price of Tatva Chintan Pharma Chem Ltd was ₹ 2,074.00.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 16, 2022 04:01 PM, the market cap of Tatva Chintan Pharma Chem Ltd stood at ₹ 4,597.02.
The latest PE ratio of Tatva Chintan Pharma Chem Ltd as of May 16, 2022 04:01 PM is 47.66
The latest PB ratio of Tatva Chintan Pharma Chem Ltd as of May 16, 2022 04:01 PM is 0.10
The 52-week high of Tatva Chintan Pharma Chem Ltd is ₹ 2,975.55 while the 52-week low is ₹ 2,000.75 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote